PlainRecalls
FDA Drug Critical Class I Ongoing

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Reported: August 7, 2024 Initiated: July 12, 2024 #D-0620-2024

Product Description

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Reason for Recall

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Details

Recalling Firm
SoloVital
Units Affected
1,331 bottles
Distribution
Nationwide within the United States
Location
Chula Vista, CA

Frequently Asked Questions

What product was recalled?
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.. Recalled by SoloVital. Units affected: 1,331 bottles.
Why was this product recalled?
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2024. Severity: Critical. Recall number: D-0620-2024.